AU2003288604A1 - Controlled release pharmaceutical compositions of tamsulosin - Google Patents

Controlled release pharmaceutical compositions of tamsulosin Download PDF

Info

Publication number
AU2003288604A1
AU2003288604A1 AU2003288604A AU2003288604A AU2003288604A1 AU 2003288604 A1 AU2003288604 A1 AU 2003288604A1 AU 2003288604 A AU2003288604 A AU 2003288604A AU 2003288604 A AU2003288604 A AU 2003288604A AU 2003288604 A1 AU2003288604 A1 AU 2003288604A1
Authority
AU
Australia
Prior art keywords
composition
tamsulosin
cellulose
mixtures
enteric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288604A
Other languages
English (en)
Inventor
Girish Kumar Jani
Ashok Rampal
Seetharaman Sritharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2003288604A1 publication Critical patent/AU2003288604A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003288604A 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin Abandoned AU2003288604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1292/DEL/2002 2002-12-20
IN1292DE2002 IN192381B (es) 2002-12-20 2002-12-20
PCT/IB2003/006072 WO2004056354A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin

Publications (1)

Publication Number Publication Date
AU2003288604A1 true AU2003288604A1 (en) 2004-07-14

Family

ID=32676755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288604A Abandoned AU2003288604A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin

Country Status (9)

Country Link
EP (1) EP1596849A1 (es)
JP (1) JP2006512358A (es)
CN (1) CN1744889A (es)
AU (1) AU2003288604A1 (es)
BR (1) BR0317567A (es)
CA (1) CA2511208A1 (es)
IN (1) IN192381B (es)
RU (1) RU2005121999A (es)
WO (1) WO2004056354A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004066991A1 (ja) * 2003-01-27 2006-05-18 アステラス製薬株式会社 タムスロシンまたはその塩の腸溶性徐放微粒子およびその製造法
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
SI1618873T1 (sl) * 2004-07-14 2007-10-31 Siegfried Generics Int Ag Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2007360B1 (en) 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008089593A1 (fr) * 2007-01-18 2008-07-31 Standard Chem. & Pharm. Co., Ltd. Preparation de tamsulosine a liberation prolongee et procede de production associe
WO2010001574A1 (ja) * 2008-07-01 2010-01-07 沢井製薬株式会社 タムスロシン塩酸塩を含有する球形微粒子の製造方法
CN101695478B (zh) * 2009-10-23 2012-01-18 江苏大学 盐酸坦索罗辛缓释微丸制剂及其制备方法
KR101423237B1 (ko) * 2010-05-04 2014-07-30 주식회사 삼양바이오팜 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
CN103315962A (zh) * 2013-02-01 2013-09-25 北京科信必成医药科技发展有限公司 一种坦索罗辛缓释微丸制剂及其制备方法
CN103142492A (zh) * 2013-02-01 2013-06-12 北京科信必成医药科技发展有限公司 一种缓释微丸制剂及其制备方法
CN103919735B (zh) * 2014-05-04 2018-04-17 翰宇药业（武汉）有限公司 一种盐酸坦索罗辛缓释微丸及其制备方法
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
EP3452016A1 (en) * 2016-05-04 2019-03-13 Aspen Park Pharmaceuticals Inc. Delayed release oral tamsulosin hydrochloride
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
KR20200078146A (ko) * 2018-12-21 2020-07-01 한미약품 주식회사 내산성이 우수한 탐수로신 염산염 함유 제약 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
NZ532589A (en) * 2001-11-07 2005-02-25 Synthon Bv Tamsulosin tablets

Also Published As

Publication number Publication date
CA2511208A1 (en) 2004-07-08
EP1596849A1 (en) 2005-11-23
RU2005121999A (ru) 2006-01-20
JP2006512358A (ja) 2006-04-13
IN192381B (es) 2004-04-10
CN1744889A (zh) 2006-03-08
WO2004056354A1 (en) 2004-07-08
BR0317567A (pt) 2005-11-22

Similar Documents

Publication Publication Date Title
AU2003288604A1 (en) Controlled release pharmaceutical compositions of tamsulosin
JP4789806B2 (ja) パントプラゾール多粒子処方
JP2720932B2 (ja) 経口投与用アセトアミノフエン錠剤の製造法及びアセトアミノフエン二層錠剤
JP6169411B2 (ja) ゾニサミドの徐放性製剤
EP1940361B1 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties
JP2008303223A (ja) 脈動用量薬剤経口送達システム
AU6699100A (en) Oral pharmaceutical forms of administration with a delayed action
CZ30093A3 (en) Pulsating systems for administering minocyclin once a day
JP2001172201A (ja) 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法
CA2199345A1 (en) Controlled-release composition
JP2002087952A (ja) 味遮蔽製薬粒子
JPH05201866A (ja) 配合製剤
JP3134187B2 (ja) 放出制御組成物
CN101977593A (zh) 包含弱碱性药物以及有机酸的给药系统
JP2011522050A (ja) バルサルタンのパルス放出
BG105325A (bg) Независещи от ефекта на храната многочастичкови фармацевтични препарати за продължително освобождаване и методи за получаването им
JP3677156B2 (ja) 医薬
WO2005009416A1 (en) Modified release compositions for minocycline
WO2003053420A1 (en) Multiple-pulse extended release formulations of clindamycin
ES2883352T3 (es) Forma de dosificación oral
CA2547586C (en) Controlled-release pharmaceutical formulation
WO2005051362A2 (en) Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
WO2004050064A1 (en) Method of manufacturing controlled release formulation using pelletizer
JP2002179554A (ja) 医 薬
Rhee et al. Controlled-release pelletized dosage forms using the extrusion-spheronization process

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period